UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
Old National Bancorp
ONB
$9.6B
| $39.9M | 0.01% |
1,539,955
-162,321
| -10% | -$3.9M |
2014 Q4
46 quarters
|
|
1977
Century Aluminum
CENX
$3.25B
| $39.9M | 0.01% |
866,821
+280,055
| +48% | +$16.8M |
2014 Q4
46 quarters
|
|
1978
WisdomTree US MidCap Fund
EZM
$951M
| $39.9M | 0.01% |
526,139
-53,881
| -9% | -$3.9M |
2014 Q4
46 quarters
|
|
1979
Lamb Weston
LW
$7.8B
| $39.8M | 0.01% |
922,194
-862,568
| -48% | -$37.2M |
2016 Q4
38 quarters
|
|
1980
PUT
CSX Corp
CSX
$96.4B
| $39.8M | 0.01% |
837,500
-500,100
| -37% | -$22.6M |
2022 Q3
15 quarters
|
|
1981
Warrior Met Coal
HCC
$4.26B
| $39.7M | 0.01% |
488,914
+99,924
| +26% | +$9.03M |
2017 Q3
35 quarters
|
|
1982
PUT
Okta
OKTA
$33.4B
| $39.6M | 0.01% |
290,200
-12,200
| -4% | -$1.15M |
2023 Q4
10 quarters
|
|
1983
CALL
iShares MSCI Taiwan ETF
EWT
$10.5B
| $39.6M | 0.01% |
364,480
+352,460
| +2,932% | +$33M |
2024 Q3
7 quarters
|
|
1984
iShares Russell Top 200 Value ETF
IWX
$3.99B
| $39.6M | 0.01% |
376,112
+23,012
| +7% | +$2.33M |
2014 Q4
46 quarters
|
|
1985
SL Green Realty
SLG
$3.5B
| $39.5M | 0.01% |
763,108
-357,288
| -32% | -$15.9M |
2014 Q4
46 quarters
|
|
1986
Ligand Pharmaceuticals
LGND
$6.27B
| $39.4M | 0.01% |
124,674
+20,094
| +19% | +$4.73M |
2014 Q4
46 quarters
|
|
1987
iShares MSCI Australia ETF
EWA
$1.27B
| $39.4M | 0.01% |
1,397,654
+121,696
| +10% | +$3.53M |
2014 Q4
46 quarters
|
|
1988
HealthEquity
HQY
$8.44B
| $39.3M | 0.01% |
435,457
-351,210
| -45% | -$29.8M |
2014 Q4
46 quarters
|
|
1989
Brady Corp
BRC
$3.87B
| $39.3M | 0.01% |
429,025
+312,487
| +268% | +$26M |
2014 Q4
46 quarters
|
|
1990
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.35B
| $39.2M | 0.01% |
1,566,179
+187,158
| +14% | +$4.69M |
2014 Q4
46 quarters
|
|
1991
Ryanair
RYAAY
$30.6B
| $39.2M | 0.01% |
604,970
+175,460
| +41% | +$10.3M |
2014 Q4
46 quarters
|
|
1992
WisdomTree Trust WisdomTree Interest Rate Hedged High Yield Bond Fund
HYZD
$313M
| $39.1M | 0.01% |
1,738,524
+158,613
| +10% | +$3.57M |
2014 Q4
46 quarters
|
|
1993
BILL Holdings
BILL
$4.45B
| $39.1M | 0.01% |
1,082,069
-204,331
| -16% | -$7.53M |
2019 Q4
26 quarters
|
|
1994
Camtek
CAMT
$4.73B
| $39.1M | 0.01% |
239,681
-33,654
| -12% | -$5.97M |
2017 Q3
35 quarters
|
|
1995
Trustmark
TRMK
$2.6B
| $39.1M | 0.01% |
848,952
-12,296
| -1% | -$548K |
2014 Q4
46 quarters
|
|
1996
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$8.21B
| $39.1M | 0.01% |
950,353
-95,828
| -9% | -$3.79M |
2023 Q4
10 quarters
|
|
1997
Morgan Stanley Direct Lending Fund
MSDL
$1.18B
| $39M | 0.01% |
2,581,090
+984,494
| +62% | +$14.9M |
2024 Q1
9 quarters
|
|
1998
Hamilton Lane
HLNE
$4.89B
| $39M | 0.01% |
494,611
-18,636
| -4% | -$1.66M |
2017 Q4
34 quarters
|
|
1999
Hinge Health
HNGE
$9.43B
| $38.9M | 0.01% |
469,257
-122,775
| -21% | -$6.67M |
2025 Q2
4 quarters
|
|
2000
Bruker
BRKR
$8.61B
| $38.9M | ﹤0.01% |
646,494
-163,402
| -20% | -$7.63M |
2014 Q4
46 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.